ACTRN12621000875808Recruiting未知
A clinical audit of opioid reduction in patients undergoing treatment with medicinal cannabis for chronic non-cancer pain
Dr Philip Finch0 sites200 target enrollmentStarted: July 6, 2021Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •Chronic non-cancer patients referred to Perth Pain Management Centre or to Dr Michael Kent who were taking opioid medications at or after the commencement of the audit (November 2020).
Exclusion Criteria
- •Cannabinoid exclusion - previous significant drug addiction, pregnancy, lactation, previous psychotic illness, age (under 18) and relative exclusions of heart and liver disease.
Investigators
Similar Trials
Completed
Not Applicable
Proactive clinical review of patients taking opioid medicines long-term for persistent pain led by clinical pharmacists in primary care teams feasibility studyChronic painMusculoskeletal DiseasesPatients prescribed opioids for 6 months or longer for persistent non-cancer painISRCTN87628403Keele University148
Suspended
Phase 4
Opioid Reduction Toolkit Reduces Opioids Prescribed and ConsumedOpioid AbuseOpioid MisusePainNCT05363436Thomas Jefferson University159
Completed
Phase 4
Effect of methadone as pain relief in day-surgery patients undergoing a laparascopic gynaecological procedureACTRN12620001131943niversity of New South Wales69
Recruiting
Phase 2
The effects of minocycline on breathing during sleep in patients prescribed opioid drugs for chronic pain.Central sleep apnoeachronic painRespiratory - Sleep apnoeaAnaesthesiology - Pain managementACTRN12613000274774Repatriation General Hospital15
Not yet recruiting
Not Applicable
An another treatment for opioid withdrawal symptomsCTRI/2020/04/024836il